Singer, C. F., Pfeiler, G., Hubalek, M., Bartsch, R., Stöger, H., Pichler, A., Petru, E., Bjelic-Radisic, V., Greil, R., Rudas, M., Maria Tea, M., Wette, V., Petzer, A. L., Sevelda, P., Egle, D., Dubsky, P. C., Filipits, M., Fitzal, F., Exner, R., Jakesz, R., Balic, M., Tinchon, C., Bago-Horvath, Z., Frantal, S., Gnant, M., & , (2020). efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). European journal of cancer, 132, 43–52. http://access.bl.uk/ark:/81055/vdc_100104360265.0x000024